- Home
- QNCX vs NTZ Comparison
QNCX vs NTZ Comparison
Compare QNCX & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- NTZ
- Stock Information
- Founded
- QNCX 2012
- NTZ 1959
- Country
- QNCX United States
- NTZ Italy
- Employees
- QNCX N/A
- NTZ N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- NTZ Home Furnishings
- Sector
- QNCX Health Care
- NTZ Consumer Discretionary
- Exchange
- QNCX Nasdaq
- NTZ Nasdaq
- Market Cap
- QNCX 47.7M
- NTZ 41.6M
- IPO Year
- QNCX 2019
- NTZ 1993
- Fundamental
- Price
- QNCX $1.68
- NTZ $2.70
- Analyst Decision
- QNCX Strong Buy
- NTZ
- Analyst Count
- QNCX 5
- NTZ 0
- Target Price
- QNCX $8.00
- NTZ N/A
- AVG Volume (30 Days)
- QNCX 235.8K
- NTZ 22.1K
- Earning Date
- QNCX 08-12-2025
- NTZ 07-02-2025
- Dividend Yield
- QNCX N/A
- NTZ N/A
- EPS Growth
- QNCX N/A
- NTZ N/A
- EPS
- QNCX N/A
- NTZ N/A
- Revenue
- QNCX N/A
- NTZ $337,653,480.00
- Revenue This Year
- QNCX N/A
- NTZ N/A
- Revenue Next Year
- QNCX N/A
- NTZ N/A
- P/E Ratio
- QNCX N/A
- NTZ N/A
- Revenue Growth
- QNCX N/A
- NTZ N/A
- 52 Week Low
- QNCX $0.51
- NTZ $2.15
- 52 Week High
- QNCX $2.45
- NTZ $6.27
- Technical
- Relative Strength Index (RSI)
- QNCX 50.83
- NTZ 32.94
- Support Level
- QNCX $1.75
- NTZ $2.55
- Resistance Level
- QNCX $2.05
- NTZ $3.00
- Average True Range (ATR)
- QNCX 0.16
- NTZ 0.21
- MACD
- QNCX -0.02
- NTZ 0.00
- Stochastic Oscillator
- QNCX 9.76
- NTZ 50.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.